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Terpenoids have been described as pharmacologically
active substances. Antibacterial, antifungal, anti-inflamma-
tory activities and cytotoxicity against cancer cell lines are
some of the biological effects described for these com-
pounds [1-4]. Kaurenic acid is a diterpene isolated from
the aerial parts of Espeletia semiglobulata (Compositae)
and its antitumor effect via apoptosis and necrosis against
melanoma cells in animal models has been described [5].
The present study researches the molecular mechanism
for this anti-melanoma effect on cells inoculated in mice.
One hundred thousand cells of melanoma B16F1 were
used for inoculation in fifteen male, 20 g weight C57BL/6
mice. There were three groups of five mice each: group A
was treated for 21 days with saline solution (0.009%/day);
group B was treated for 21 days with Taxol (14.5 mg/kg/
week); and group C was treated with kaurenic acid for
21 days (1 mg/kg/day). Two animals in group C died dur-
ing the treatment. The expression of genes for proteins
Bcl-2, Bax-a, Bcl-xL, c-Myc, P53, ICE (caspase 1), ICH1
(caspase 2), CPP32 (caspase 3), Apa F1 (activator), TNF-a,
eNOS, Il1-b, iNOS, nNOS, Flice (caspase 8), MCH6 (cas-
pase 9) involved in different apoptotic pathways, was qua-
litatively assessed by using Multiplex PCR Maxim Biotech
Inc. Kits for Mouse Apoptotic Genes, with GAPDH and
18S as internal controls in cDNA synthesized by Trizol
method [6]. Each PCR was repeated twice in the same
conditions for each sample. Amplification products were
visualized in agarose gels cored with ethidium bromide
and illuminated with ultraviolet light. The results showed
that there was no expression of Bcl-xL in any of the ani-
mals from groups B and C. Furthermore, there was no
expression of iNOS, nNOS and eNOS in samples from
group C. Other evaluated genes were present in all groups.
The alteration in the expression of the Bcl-xL gene (anti-
apoptotic protein) and nitric oxide family proteins could
be crucial events for the anti-melanoma effect. Kaurenic
acid could offer potential usefulness as an agent for ther-
apy of this cancer.
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